Comparative evaluation of single and combination chemotherapy in uterine cancer cell lines
Authors:
Open Access
- 1 September 1991
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 42 (3) , 227-232
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Application of an ATP-bioluminescence assay in human tumor chemosensitivity testingGynecologic Oncology, 1988
- Randomized phase II studies of cisplatin and a combination of cyclophosphamide-doxorubicin-cisplatin (CAP) in patients with progestin-refractory advanced endometrial carcinomaGynecologic Oncology, 1987
- Melphalan, 5-fluorouracil, and medroxyprogesterone acetate in metastatic endometrial carcinomaInternational Journal of Gynecology & Obstetrics, 1987
- Melphalan, 5-Fluorouracil, and Medroxyprogesterone Acetate in Metastatic Endometrial CarcinomaObstetrics & Gynecology, 1986
- Treatment of recurent endometrial adenocarcinoma with a combination of doxorubicin and cisplatinAmerican Journal of Obstetrics and Gynecology, 1984
- Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitorsAdvances in Enzyme Regulation, 1984
- Treatment of advanced endometrial adenocarcinoma with cis-dichlorodiammine platinum (II) after intensive prior therapy☆Gynecologic Oncology, 1980
- Perspectives on research in gynecologic oncology.Treatment protocolsCancer, 1976
- Nonhormonal chemotherapy of endometrial adenocarcinoma: A reviewCancer, 1974
- The Use of Drugs in Combination for the Treatment of CancerNew England Journal of Medicine, 1973